However, when type 1 diabetes mellitus (T1DM) patients (with low insulin production) were provided a subcutaneous GIP infusion, they showed an increase in NEFA levels during the first 3 h, without changes in fasting plasma levels of C-peptide or insulin (Heimburger et al. 2022). This evidence concerns the gene GIP and type 1 diabetes mellitus.